Taken together, our results suggest that nAMD patients had significantly higher intraocular levels of VCAM-1, ICAM-1, CD44 and CD62L and that higher level of VCAM-1 is related to macular fibrosis and increased central retinal thickness (a sign of macular oedema). This evidence concerns the gene ICAM1 and macular retinal edema.